Silvana Maria Elói-Santos

Author PubWeight™ 11.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis 2011 1.10
2 Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. Vaccine 2010 0.95
3 Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 2008 0.94
4 Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination. Clin Vaccine Immunol 2009 0.94
5 Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory. J Immunol Methods 2006 0.89
6 Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect 2007 0.89
7 17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children. PLoS One 2012 0.87
8 [Anti-live Leishmania (Viannia) braziliensis promastigote antibodies, detected by flow cytometry, to identify active infection in american cutaneous leishmaniasis]. Rev Soc Bras Med Trop 2003 0.86
9 Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens. BMC Infect Dis 2012 0.84
10 Variation rhythms of lymphocyte subsets during healthy aging. Neuroimmunomodulation 2008 0.83
11 The use of IgG antibodies in conventional and non-conventional immunodiagnostic tests for early prognosis after treatment of Chagas disease. J Immunol Methods 2011 0.82
12 Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect. Exp Parasitol 2011 0.79
13 Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease. Redox Rep 2010 0.75